Position in HROW
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$5,433,424
-$2,025,895 QoQ
Shares Held
154,096
+1.2% QoQ
Ownership
0.413%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2021
8 quarters on record
Voting authority
Sole 37.50973419167272.ToString("F0")%
Shared 0.ToString("F0")%
None 62.49026580832727.ToString("F0")%
Common Shares in HROW Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026FIRST TRUST ADVISORS LP holds $590,881,836 across 26 Drug Manufacturers - Specialty & Generic names. HROW ranks #14 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
270,578 | $160,447,342 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
959,217 | $126,367,247 | |
| 3 | ALKS |
Alkermes plc.
|
2,968,785 | $104,976,237 | |
| 4 | ZTS |
Zoetis Inc.
|
570,393 | $67,426,156 | |
| 5 | TAK |
Takeda Pharmaceutical Co Ltd
|
1,971,074 | $36,504,290 | |
| 6 | PRGO |
PERRIGO Co plc
|
1,496,244 | $16,069,660 | |
| 7 | LQDA |
Liquidia Corp
|
279,475 | $10,547,386 | |
| 8 | AMRX |
Amneal Pharmaceuticals, Inc.
|
757,157 | $9,411,461 |
All Filings in HROW
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,433,424 | 154,096 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $7,459,319 | 152,231 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $7,808,628 | 162,072 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $2,538,820 | 83,131 | Shares | Sole | 2025-08-13 | |
| 2022-06-30 | $264,271 | 36,301 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $253,172 | 37,122 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $339,353 | 39,277 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $312,805 | 34,412 | Shares | Sole | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||